MedTech Resources

De Novo device

MISHA Knee System

Moximed, Inc. · Medial Knee Implanted Shock Absorber (QVV, Class II) · First FDA decision Apr 10, 2023, newest Apr 10, 2023Knee osteoarthritis

Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed

FDA decisions

1

Breakthrough-designated

Device trials

4

Naming "MISHA"

MAUDE reports

18

Brand "MISHA", since 2015

PubMed studies

24

Mentioning "MISHA"

AI summary across all sources

Written by Claude (Anthropic's AI) from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.

FDA decisions

The newest 1 of 1 decisions filed under this name.

Medicare coverage

National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.

How devices get paid for

No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.

Clinical trials

Device studies on ClinicalTrials.gov that name "MISHA", any status and sponsor, newest update first.

Open in Trial Radar
  • MoximedNot on our public-company list

    NCT03671213 · 81 participants · Start Sep 19, 2018 · Primary completion Jan 17, 2022

    Device: Calypso Knee System (Implantable Shock Absorber) · For: Osteoarthritis, Knee

    Sites: Columbia, Missouri; New York, New York; Columbus, Ohio · 5 sites in all

  • MoximedNot on our public-company list

    NCT03838978 · 81 participants · Start Feb 8, 2019 · Primary completion Jan 17, 2022

    Device: Calypso Knee System (Implantable Shock Absorber) · For: Osteoarthritis, Knee

    Sites: Ghent, Belgium; Lodz, Poland; Lublin, Poland · 5 sites in all

  • MoximedNot on our public-company list

    NCT06118892 · 120 participants (planned) · Start Nov 3, 2023 · Primary completion Jun 30, 2030

    Device: MISHA Knee System · For: Osteo Arthritis Knee

    Sites: Sonoma, California; Raleigh, North Carolina; Portland, Oregon · 4 sites in all

  • MOTION Clinical TrialPivotal-lookingRecruiting

    MoximedNot on our public-company list

    NCT06843980 · 100 participants (planned) · Start Feb 13, 2025 · Primary completion Apr 30, 2026

    Device: MISHA Knee System · For: Osteoarthritis, Knee

    Sites: Davis, California; Oceanside, California; Sacramento, California · 9 sites in all

Adverse event reports (MAUDE)

Reports received since 2015 naming the brand "MISHA", and for the whole product code for context.

This brand

18 reports: 7 malfunction, 11 injury, 0 death

Whole product code QVV

18 reports: 7 malfunction, 11 injury, 0 death

Newest reports for this brand

All reports in MAUDE Monitor

Recalls

From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

No recall in FDA's data is linked to these FDA numbers.

Published research

The most relevant PubMed records for "MISHA"[tiab]. The summary above synthesizes these.

PubMedGoogle ScholarLiterature search

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.